Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis

doi:10.1093/postmj/qgad140

Xinxin Zhong, Ao Lin, Jian Luo, Yeqin Li, Jinlan Chen, Chao Ning, Fu Cao

Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis

General Medicine

Abstract Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

Web-based, modern reference management
Collaborate and share with fellow researchers
Integration with Overleaf
Comprehensive BibTeX/BibLaTeX support
Save articles and websites directly from your browser
Search for new articles from a database of tens of millions of references

Try out CiteDrive

Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

More from our Archive

Virtual education strategies in the context of sustainable health care and medical education: A topic modelling analysis of four decades of research

Perinatal Depression and Risk of Suicidal Behavior

The new frontier: Clinical consequences of long COVID

The infection-tolerant white-footed deermouse tempers interferon responses to endotoxin in comparison to the mouse and rat

Hospital at Home Program for the Treatment of Pediatric Osteoarticular Infections

Xylazine in Overdose Deaths and Forensic Drug Reports in US States, 2019-2022

Feasibility and performance of in-house red blood cell reagents to detect unexpected antibodies in immunized patients in Burkina Faso

Dabrafenib and trametinib as a promising treatment option for pediatric population with low-grade gliomas that have BRAF V600E mutation; a breakthrough in the field of neuro-oncology

Exposure to Residential Green Space and Bone Mineral Density in Young Children

Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates